Clinical Trial Update: Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata [Phase 2]

View source ↗

Summary

Phase 2 open-label study of ATI-50002 topical solution in adults with eyebrow loss due to alopecia areata completed with posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata
• Alopecia Totalis
• Alopecia Universalis

Drugs mentioned

• ATI-50002 topical solution (ATI-50002)

Snippet

Sponsor: Aclaris Therapeutics, Inc. | Conditions: Alopecia Areata, Alopecia Totalis | Phase 2 | Status: COMPLETED | Results posted: 2019-12-11